StockData
Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc. (LNTH) stock

LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3014% above fair value
$102.00+0.20 (+0.20%)

Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –

Lantheus gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Lantheus's gross profit for the twelve months ending Jun 30, 2026 was $936.02M, down 3.4% year over year. For fiscal 2025 it was $941.95M, down 4.7% from the year before. Over ten years it grew 21.4% a year on average. The highest annual figure on record is $988.29M in fiscal 2024.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$941.95M-4.7%
FY2024Dec 31, 2024$988.29M+39.3%
FY2023Dec 31, 2023$709.54M+22.0%
FY2022Dec 31, 2022$581.70M+209.9%
FY2021Dec 31, 2021$187.70M+35.3%
FY2020Dec 31, 2020$138.76M-20.6%
FY2019Dec 31, 2019$174.81M-0.0%
FY2018Dec 31, 2018$174.89M+7.9%
FY2017Dec 31, 2017$162.14M+17.7%
FY2016Dec 31, 2016$137.78M+1.7%
FY2015Dec 31, 2015$135.52M+8.0%
FY2014Dec 31, 2014$125.52M+62.3%
FY2013Dec 31, 2013$77.36M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$241.86M+0.4%
Q1 FY2026Mar 31, 2026$230.92M-2.9%
Q4 FY2025Dec 31, 2025$240.88M-3.1%
Q3 FY2025Sep 30, 2025$222.37M-8.2%
Q2 FY2025Jun 30, 2025$241.01M-5.8%
Q1 FY2025Mar 31, 2025$237.70M-1.7%
Q4 FY2024Dec 31, 2024$248.55M+8.1%
Q3 FY2024Sep 30, 2024$242.13M+21.1%
Q2 FY2024Jun 30, 2024$255.77M+26.2%
Q1 FY2024Mar 31, 2024$241.85M+213.8%
Q4 FY2023Dec 31, 2023$229.87M+37.5%
Q3 FY2023Sep 30, 2023$199.95M+35.6%
Q2 FY2023Jun 30, 2023$202.65M+46.8%
Q1 FY2023Mar 31, 2023$77.08M-40.3%
Q4 FY2022Dec 31, 2022$167.17M+188.7%
Q3 FY2022Sep 30, 2022$147.43M+245.5%
Q2 FY2022Jun 30, 2022$138.03M+199.5%
Q1 FY2022Mar 31, 2022$129.07M+214.6%
Q4 FY2021Dec 31, 2021$57.91M+49.8%
Q3 FY2021Sep 30, 2021$42.67M+17.7%
Q2 FY2021Jun 30, 2021$46.09M+78.3%
Q1 FY2021Mar 31, 2021$41.03M+8.0%
Q4 FY2020Dec 31, 2020$38.65M-13.3%
Q3 FY2020Sep 30, 2020$36.26M-12.8%
Q2 FY2020Jun 30, 2020$25.85M-42.0%
Q1 FY2020Mar 31, 2020$38.00M-13.8%
Q4 FY2019Dec 31, 2019$44.57M+1.6%
Q3 FY2019Sep 30, 2019$41.59M-7.3%
Q2 FY2019Jun 30, 2019$44.57M+1.7%
Q1 FY2019Mar 31, 2019$44.08M+4.2%
Q4 FY2018Dec 31, 2018$43.85M+15.7%
Q3 FY2018Sep 30, 2018$44.89M+16.5%
Q2 FY2018Jun 30, 2018$43.85M-4.6%
Q1 FY2018Mar 31, 2018$42.31M+6.4%
Q4 FY2017Dec 31, 2017$37.90M+9.4%
Q3 FY2017Sep 30, 2017$38.53M+14.4%
Q2 FY2017Jun 30, 2017$45.95M–
Q1 FY2017Mar 31, 2017$39.76M–
Q4 FY2016Dec 31, 2016$34.65M–
Q3 FY2016Sep 30, 2016$33.68M–

More Lantheus figures

See a number that looks wrong?